Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aron Cohen

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Virological Methods|July 25, 2022
Potential pitfalls in analysing a SARS-CoV-2 RT-PCR assay and how to standardise data interpretationMelvyn Smith, Kate El Bouzidi, Simon Bengen, et al.
The Journal of Chemical Physics|June 8, 2023
Optimizing Jastrow factors for the transcorrelated methodJ Philip Haupt, Seyed Mohammadreza Hosseini, Pablo López Ríos, et al.
The Journal of Sexual Medicine|May 23, 2008
Patients' knowledge about risk factors for erectile dysfunction is poorMartin K Baumgartner, Thomas Hermanns, Aron Cohen, et al.
Journal for Immunotherapy of Cancer|January 29, 2020
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitorsCharles Dolladille, Stephane Ederhy, Stéphane Allouche, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Virological Methods|July 25, 2022
Potential pitfalls in analysing a SARS-CoV-2 RT-PCR assay and how to standardise data interpretationMelvyn Smith, Kate El Bouzidi, Simon Bengen, et al.
The Journal of Chemical Physics|June 8, 2023
Optimizing Jastrow factors for the transcorrelated methodJ Philip Haupt, Seyed Mohammadreza Hosseini, Pablo López Ríos, et al.
The Journal of Sexual Medicine|May 23, 2008
Patients' knowledge about risk factors for erectile dysfunction is poorMartin K Baumgartner, Thomas Hermanns, Aron Cohen, et al.
Journal for Immunotherapy of Cancer|January 29, 2020
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitorsCharles Dolladille, Stephane Ederhy, Stéphane Allouche, et al.
Pageof 1